* Equillium Inc EQ.OQ EQ.O is expected to show a no change
in quarterly revenue when it reports results on August 10
(estimated).
* Refinitiv's mean analyst estimate for Equillium Inc is for a
loss of 31 cents per share. For the same quarter last year, the
company reported a loss of 37 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Equillium Inc
is $13, about 53.5% above its last closing price of $6.05.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.33 -0.32 -0.33 Missed -2.5
Dec. 31 2020 -0.37 -0.40 -0.36 Beat 10.4
Sep. 30 2020 -0.42 -0.40 -0.31 Beat 22
Jun. 30 2020 -0.45 -0.45 -0.37 Beat 17.8
Mar. -0.43 -0.42 -0.45 Missed -7.8
31 2020
Dec. 31 2019 -0.41 -0.39 -0.44 Missed -13.5
Sep. 30 2019 -0.39 -0.40 -0.35 Beat 11.8
Jun. 30 2019 -0.39 -0.34 -0.35 Missed -2.2
This summary was machine generated August 6 at 15:46 GMT. All
figures in US dollars unless otherwise stated